The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Conditions: Metastatic Breast Cancer Interventions: Drug: Palbociclib; Drug: Ribociclib Sponsors: American Society of Clinical Oncology; Patient-Centered Outcomes Research Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials